Literature DB >> 15326254

Progression despite replacement of a myopathic form of coenzyme Q10 defect.

K Auré1, J F Benoist, H Ogier de Baulny, N B Romero, O Rigal, A Lombès.   

Abstract

The authors report 7 years of follow-up evaluation of a patient with coenzyme Q10 (CoQ10) deficiency. Initial symptoms of exercise intolerance and hyperlactatemia improved markedly with substitutive treatment. However, CoQ(10) supplementation did not prevent the onset of a cerebellar syndrome. A switch to idebenone treatment resulted in clinical and metabolic worsening, which disappeared with subsequent CoQ10 treatment. CoQ10 defects may cause progressive neurologic disease despite supplementation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326254     DOI: 10.1212/01.wnl.0000134607.76780.b2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

Review 1.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

Review 2.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

Review 3.  Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency.

Authors:  John M Land; Simon J R Heales; Andrew J Duncan; Iain P Hargreaves
Journal:  Neurochem Res       Date:  2006-12-21       Impact factor: 3.996

4.  A history of mitochondrial diseases.

Authors:  Salvatore Dimauro
Journal:  J Inherit Metab Dis       Date:  2010-05-21       Impact factor: 4.982

5.  176th ENMC International Workshop: diagnosis and treatment of coenzyme Q₁₀ deficiency.

Authors:  Shamima Rahman; Catherine F Clarke; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2011-07-01       Impact factor: 4.296

6.  Clinical presentations of coenzyme q10 deficiency syndrome.

Authors:  Catarina M Quinzii; Valentina Emmanuele; Michio Hirano
Journal:  Mol Syndromol       Date:  2014-07

7.  The regulation of coenzyme q biosynthesis in eukaryotic cells: all that yeast can tell us.

Authors:  Isabel González-Mariscal; Elena García-Testón; Sergio Padilla; Alejandro Martín-Montalvo; Teresa Pomares Viciana; Luis Vazquez-Fonseca; Pablo Gandolfo Domínguez; Carlos Santos-Ocaña
Journal:  Mol Syndromol       Date:  2014-07

8.  Cerebellar Ataxia and Coenzyme Q Deficiency through Loss of Unorthodox Kinase Activity.

Authors:  Jonathan A Stefely; Floriana Licitra; Leila Laredj; Andrew G Reidenbach; Zachary A Kemmerer; Anais Grangeray; Tiphaine Jaeg-Ehret; Catherine E Minogue; Arne Ulbrich; Paul D Hutchins; Emily M Wilkerson; Zheng Ruan; Deniz Aydin; Alexander S Hebert; Xiao Guo; Elyse C Freiberger; Laurence Reutenauer; Adam Jochem; Maya Chergova; Isabel E Johnson; Danielle C Lohman; Matthew J P Rush; Nicholas W Kwiecien; Pankaj K Singh; Anna I Schlagowski; Brendan J Floyd; Ulrika Forsman; Pavel J Sindelar; Michael S Westphall; Fabien Pierrel; Joffrey Zoll; Matteo Dal Peraro; Natarajan Kannan; Craig A Bingman; Joshua J Coon; Philippe Isope; Hélène Puccio; David J Pagliarini
Journal:  Mol Cell       Date:  2016-08-04       Impact factor: 17.970

9.  Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability.

Authors:  Lubov Blumkin; Esther Leshinsky-Silver; Ayelet Zerem; Keren Yosovich; Tally Lerman-Sagie; Dorit Lev
Journal:  JIMD Rep       Date:  2013-09-19

10.  Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects.

Authors:  Luis C López; Catarina M Quinzii; Estela Area; Ali Naini; Shamima Rahman; Markus Schuelke; Leonardo Salviati; Salvatore Dimauro; Michio Hirano
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.